Sara Ghorashian MD, PhD, FRCPath

Dr. Sara Ghorashian qualified from Oxford University and undertook hematology training at the Hammersmith and Royal Free Hospitals. She obtained a PhD at University College London (UCL) in the use of gene-engineered T cells for cancer immunotherapy. More recently, her post-doctoral studies at the UCL Great Ormond Street Institute of Child Health involved the translation of CD19CAR T cells as therapy for childhood acute lymphoblastic leukaemia (ALL) from bench to bedside. Her research interests are cellular immunotherapy for haematological malignancies and T-cell immunobiology.

She has clinical interests in paediatric malignant haematology and leads cell therapy and research within the department. She is a co-investigator on two CAR T cell studies for ALL and is actively involved in implementing new studies in order to improve outcomes for children with high-risk or relapsed haematological malignancies.